← Back to Discover
ADAR1 Capital Management, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $2,185,183,006
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $240,494,722
- PROTAGONIST THERAPEUTICS INC · COM · 74366E102 · shares: $117,782,587
- ROIVANT SCIENCES LTD · SHS · G76279101 · shares: $111,726,513
- STATE STR SPDR S&P 500 ETF T · TR UNIT · 78462F103 · shares: $96,398,299
- IMMUNOVANT INC · COM · 45258J102 · shares: $89,802,487
- ZAI LAB LTD · ADR · 98887Q104 · shares: $64,011,646
- AGIOS PHARMACEUTICALS INC · COM · 00847X104 · shares: $47,799,647
- CRINETICS PHARMACEUTICALS IN · COM · 22663K107 · shares: $45,730,234
- EA SERIES TRUST · ALPHA ARCH 1-3 · 02072L565 · shares: $39,473,966
- CYTOKINETICS INC · COM NEW · 23282W605 · shares: $39,009,097
Reported holdings
277 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| AVALYN PHARMACEUTICALS INC | COM SHS | 05348Y105 | — | 146,447 shares | $4,821,035 |
| ARS PHARMACEUTICALS INC | COM | 82835W108 | — | 600,999 shares | $4,814,002 |
| ATAIBECKLEY INC | COM SHS | 04650F101 | — | 913,242 shares | $4,812,785 |
| PRELUDE THERAPEUTICS INC | COM | 74065P101 | — | 900,900 shares | $4,801,797 |
| JATT II ACQUISITION CORP | ORD SHS | G50765109 | — | 417,724 shares | $4,745,345 |
| REIN THERAPEUTICS INC | COM NEW | 00887A204 | — | 4,500,000 shares | $4,680,000 |
| PEPGEN INC | COM | 713317105 | — | 2,591,085 shares | $4,663,953 |
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | — | 278,961 shares | $4,572,171 |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | — | 1,210,117 shares | $4,126,499 |
| APOGEE THERAPEUTICS INC | COM | 03770N101 | — | 31,000 shares | $4,114,630 |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | — | 118,623 shares | $4,020,133 |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | — | 421,787 shares | $3,956,362 |
| BIOGEN INC | COM | 09062X103 | — | 17,900 shares | $3,867,474 |
| XENCOR INC | COM | 98401F105 | — | 232,560 shares | $3,744,216 |
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | — | 338,373 shares | $3,715,336 |
| SPRUCE BIOSCIENCES INC | COM NEW | 85209E208 | — | 67,717 shares | $3,656,718 |
| PHARVARIS N V | COM | N69605108 | — | 105,528 shares | $3,649,158 |
| ENGENE THERAPEUTICS INC | COM | 29286X101 | — | 2,104,986 shares | $3,641,626 |
| PALISADE BIO INC | COM | 696389402 | — | 1,726,662 shares | $3,608,724 |
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | — | 940,512 shares | $3,592,756 |
| BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | — | 20,000 principal | $3,461,880 |
| SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | — | 437,500 shares | $3,381,875 |
| BEONE MEDICINES LTD | SPONSORED ADS | 07725L102 | — | 11,701 shares | $3,334,434 |
| INVIVYD INC | COM | 00534A102 | — | 3,807,427 shares | $3,321,599 |
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | — | 220,462 shares | $3,207,722 |
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | — | 652,750 shares | $3,165,838 |
| RELMADA THERAPEUTICS INC | COM | 75955J402 | — | 451,918 shares | $3,127,273 |
| DELCATH SYS INC | COM NEW | 24661P807 | — | 224,385 shares | $2,825,007 |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | — | 49,000 shares | $2,803,780 |
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | — | 191,869 shares | $2,795,531 |
| KEROS THERAPEUTICS INC | COM | 492327101 | — | 246,818 shares | $2,640,953 |
| ELEDON PHARMACEUTICALS INC | COM | 28617K101 | — | 647,812 shares | $2,552,379 |
| SANOFI SA | SPONSORED ADR | 80105N105 | — | 57,100 shares | $2,435,886 |
| AMERICAN EXCEPTIONALISM ACQU | ORD CL A | G0273J101 | — | 205,408 shares | $2,427,923 |
| TANGO THERAPEUTICS INC | COM | 87583X109 | — | 76,761 shares | $2,399,549 |
| INTUITIVE SURGICAL INC | COM NEW | 46120E602 | — | 6,030 shares | $2,398,010 |
| INOVIO PHARMACEUTICALS INC | COM SHS | 45773H409 | — | 2,143,910 shares | $2,358,301 |
| OMNIAB INC | COM | 68218J103 | — | 947,412 shares | $2,330,634 |
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | — | 90,593 shares | $2,181,479 |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | 10919W405 | — | 30,300 shares | $2,127,060 |
| ORUKA THERAPEUTICS INC | COM | 687604108 | — | 20,840 shares | $1,983,343 |
| VYNE THERAPEUTICS INC | COM | 92941V308 | — | 2,950,000 shares | $1,919,565 |
| MCKESSON CORP | COM | 58155Q103 | — | 2,500 shares | $1,889,000 |
| LEXICON PHARMACEUTICALS INC | COM NEW | 528872302 | — | 750,000 shares | $1,800,000 |
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | — | 117,101 shares | $1,749,489 |
| CUE BIOPHARMA INC | COM | 22978P205 | — | 55,193 shares | $1,741,891 |
| SATELLOS BIOSCIENCE INC | COM | 80401L803 | — | 222,555 shares | $1,731,478 |
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | — | 26,913 shares | $1,721,086 |
| CONNECT BIOPHARMA HLDGS LTD | SHS | G23549101 | — | 700,000 shares | $1,666,000 |
| COHEN CIRCLE ACQUISIT CORP I | UNIT 07/01/2030 | G2254C105 | — | 150,000 shares | $1,576,500 |
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | — | 435,500 shares | $1,489,410 |
| FIRST TRACKS BIOTHERAPEUTICS | ORD SHS | 337185102 | — | 71,910 shares | $1,446,829 |
| EVOMMUNE INC | COM SHS | 30054Y107 | — | 104,035 shares | $1,382,625 |
| C4 THERAPEUTICS INC | COM STK | 12529R107 | — | 291,957 shares | $1,363,439 |
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | — | 133,000 shares | $1,330,000 |
| SUPERNUS PHARMACEUTICALS | COM | 868459108 | — | 27,842 shares | $1,294,931 |
| NOVO-NORDISK A S | ADR | 670100205 | — | 27,000 shares | $1,294,380 |
| AVANTOR INC | COM | 05352A100 | — | 130,000 shares | $1,287,000 |
| INMED PHARMACEUTICALS INC | COM NEW | 457637700 | — | 800,000 shares | $1,240,000 |
| PROMIS NEUROSCIENCES INC | COM SHS | 74346M505 | — | 92,850 shares | $1,221,906 |
| ARROWHEAD PHARMACEUTICALS IN | NOTE 1/1 | 04280AAC4 | — | 10,000 principal | $1,190,560 |
| ARTIVA BIOTHERAPEUTICS INC | COM | 04317A107 | — | 118,624 shares | $1,150,653 |
| TENAYA THERAPEUTICS INC | COM | 87990A106 | — | 1,555,500 shares | $1,149,670 |
| ALX ONCOLOGY HLDGS INC | COM | 00166B105 | — | 533,660 shares | $1,104,676 |
| ALEXANDRIA REAL ESTATE EQ IN | COM | 015271109 | — | 19,500 shares | $1,030,575 |
| CARTESIAN THERAPEUTICS INC | COM NEW | 816212302 | — | 98,877 shares | $1,030,298 |
| CYCLERION THERAPEUTICS INC | COM | 23255M204 | — | 298,757 shares | $1,012,786 |
| ELECTRONIC ARTS INC | COM | 285512109 | — | 4,936 shares | $1,012,077 |
| TRAVERE THERAPEUTICS INC | NOTE 0.500% 5/1 | 89422GAB3 | — | 10,000 principal | $1,000,000 |
| BIONTECH SE | SPONSORED ADS | 09075V102 | — | 10,600 shares | $986,330 |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | — | 38,955 shares | $985,562 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 42,821 shares | $951,054 |
| MAPLIGHT THERAPEUTICS INC | COM | 56565P103 | — | 26,497 shares | $949,652 |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | — | 17,500 shares | $939,225 |
| KEEN VISION ACQUISITION CORP | SHS | G52443119 | CALL | 75,000 shares | $930,000 |
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | — | 160,000 shares | $929,600 |
| AURA BIOSCIENCES INC | COM | 05153U107 | — | 130,152 shares | $924,079 |
| CHURCHILL CAP CORP XI | CL A ORD SHS | G2131A108 | — | 50,000 shares | $872,500 |
| KAZIA THERAPEUTICS LTD | SPONSORED ADS | 48669G303 | — | 61,550 shares | $866,624 |
| NUVALENT INC | COM | 670703107 | — | 6,942 shares | $857,337 |
| LARIMAR THERAPEUTICS INC | COM | 517125100 | — | 272,745 shares | $831,872 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 18,322 shares | $786,197 |
| ADAGIO MED HLDGS INC | COM | 00534B100 | — | 1,205,447 shares | $785,469 |
| ATRIUM THERAPEUTICS INC | COM | 04965N104 | — | 57,688 shares | $775,904 |
| THERAPEUTICSMD INC | COM NEW | 88338N206 | — | 342,447 shares | $756,808 |
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | — | 20,000 shares | $745,400 |
| SI BONE INC | COM | 825704109 | — | 45,000 shares | $734,400 |
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | PUT | 40,100 shares | $720,196 |
| ROYALTY PHARMA PLC | SHS CLASS A | G7709Q104 | — | 12,500 shares | $700,875 |
| EVOLUS INC | COM | 30052C107 | — | 100,000 shares | $694,000 |
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | CALL | 20,000 shares | $667,800 |
| IBIO INC | COM NEW | 451033708 | — | 375,531 shares | $657,179 |
| FORWARD AIR CORP | COM | 34986A104 | — | 48,241 shares | $651,736 |
| GERON CORP | COM | 374163103 | — | 505,817 shares | $647,446 |
| STRYKER CORPORATION | COM | 863667101 | — | 2,000 shares | $629,680 |
| NOVO-NORDISK A S | ADR | 670100205 | CALL | 13,000 shares | $623,220 |
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | — | 146,090 shares | $607,734 |
| MACROGENICS INC | COM | 556099109 | — | 129,822 shares | $599,778 |
| GILEAD SCIENCES INC | COM | 375558103 | — | 4,648 shares | $587,228 |
| NATERA INC | COM | 632307104 | — | 2,147 shares | $582,803 |